{"id":11950,"date":"2025-11-18T13:45:31","date_gmt":"2025-11-18T12:45:31","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=11950"},"modified":"2026-03-12T15:23:37","modified_gmt":"2026-03-12T14:23:37","slug":"amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/","title":{"rendered":"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance"},"content":{"rendered":"\n<p><strong><strong>Organis\u00e9e \u00e0 l\u2019\u00e9chelon mondial, l\u2019\u00abAMR Awareness Week\u00bb a pour but de sensibiliser le grand public \u00e0 l\u2019antibior\u00e9sistance et de faire progresser les approches de solutions. Cette s\u00e9rie de blogs propose un aper\u00e7u du r\u00f4le de l\u2019industrie pharmaceutique dans la lutte contre l\u2019antibior\u00e9sistance.<\/strong><\/strong><\/p>\n\n\n\n<p>On appelle antibior\u00e9sistance ou r\u00e9sistance aux antibiotiques la capacit\u00e9 des bact\u00e9ries \u00e0 s\u2019adapter et \u00e0 r\u00e9sister \u00e0 l\u2019effet des antibiotiques. Les bact\u00e9ries r\u00e9sistantes peuvent rendre le traitement d\u2019une infection plus difficile, plus long, voire dans le pire des cas impossible. Lorsque nous prenons un antibiotique, celui-ci tue la plupart des bact\u00e9ries qui ont caus\u00e9 l\u2019infection. Mais certaines bact\u00e9ries survivent car elles sont porteuses d\u2019une <strong>mutation<\/strong> g\u00e9n\u00e9tique qui les <strong>rend r\u00e9sistantes<\/strong>. Ces bact\u00e9ries survivantes peuvent se multiplier et transmettre leur r\u00e9sistance.<\/p>\n\n\n\n<p>Ainsi, avec le temps, des souches enti\u00e8res de bact\u00e9ries voient le jour contre lesquelles certains antibiotiques sont impuissants. Les bact\u00e9ries sont aussi capables de transmettre leur r\u00e9sistance \u00e0 d\u2019autres bact\u00e9ries, y compris de tout autre type. De ce fait, le probl\u00e8me s\u2019\u00e9tend rapidement. Plus on emploie les antibiotiques fr\u00e9quemment, que ce soit chez l\u2019\u00eatre humain, dans l\u2019\u00e9levage ou en agriculture, plus la pression exerc\u00e9e sur les bact\u00e9ries est grande. Les souches sensibles disparaissent, les souches r\u00e9sistantes survivent.<\/p>\n\n\n\n<p>Dans le monde entier, les tendances dans le domaine des r\u00e9sistances signalent une baisse d\u2019efficacit\u00e9 des antibiotiques et, selon les pronostics, les r\u00e9sistances pourraient mener d\u2019ici 2050 \u00e0 dix millions de d\u00e9c\u00e8s au monde par ann\u00e9e <a href=\"https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf\">[1]<\/a>.<\/p>\n\n\n\n<p>Un facteur capital qui contribue au d\u00e9veloppement de r\u00e9sistances est <strong>l\u2019emploi trop fr\u00e9quent ou inad\u00e9quat d\u2019antibiotiques<\/strong> chez l\u2019\u00eatre humain, mais aussi en m\u00e9decine v\u00e9t\u00e9rinaire et dans l\u2019\u00e9levage.<\/p>\n\n\n\n<p>D\u2019autres facteurs sont les suivants:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Erreurs d\u2019utilisation:<\/strong>&nbsp;par exemple traitement trop court ou interruption du traitement.<\/li>\n\n\n\n<li><strong>Erreurs de dosage:<\/strong>&nbsp;pas assez d\u2019antibiotiques ou antibiotiques inutilement puissants.<\/li>\n<\/ul>\n\n\n\n<p>Ceci favorise le d\u00e9veloppement de r\u00e9sistances et les bact\u00e9ries d\u00e9j\u00e0 r\u00e9sistantes survivent, se multiplient et se r\u00e9pandent. Il est donc important de prendre les antibiotiques de mani\u00e8re responsable et conform\u00e9ment \u00e0 la prescription de son\/sa m\u00e9decin. En observant l\u2019emploi d\u2019antibiotiques en Suisse, on peut constater que 87 pourcent des antibiotiques sont utilis\u00e9s dans le secteur ambulatoire et 13 pourcent dans les h\u00f4pitaux. Il y a des diff\u00e9rences entre les h\u00f4pitaux et le secteur ambulatoire, mais aussi entre les r\u00e9gions linguistiques: la Suisse romande se classe en premi\u00e8re place de la consommation d\u2019antibiotiques par personne tandis que la Suisse al\u00e9manique se situe en troisi\u00e8me position <a href=\"https:\/\/www.newsd.admin.ch\/newsd\/message\/attachments\/90528.pdf\">[2]<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ampleur-de-la-problematique\"><strong>Ampleur de la probl\u00e9matique<\/strong> <\/h2>\n\n\n\n<p>L\u2019apparition de r\u00e9sistances a des cons\u00e9quences d\u2019une grande port\u00e9e. D\u2019apr\u00e8s l\u2019OMS, les antibior\u00e9sistances ont augment\u00e9 de 40 pourcent entre 2018 et 2023 pour les combinaisons de bact\u00e9ries et antibiotiques \u00e9tudi\u00e9es. Il y a aussi de grandes diff\u00e9rences entre les r\u00e9gions du monde, la plus fortement touch\u00e9e \u00e9tant l\u2019Asie du Sud-Est.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2025\/11\/image-15.png\" alt=\"\" class=\"wp-image-31244\"\/><figcaption class=\"wp-element-caption\"><em>Source: xiv | Median AMR in 93 infection type\u2013bacterial pathogen\u2013antibiotic combinations, by WHO region, 2023, Global antibiotic resistance surveillance report 2025<\/em>.<\/figcaption><\/figure>\n<\/div>\n\n\n<p>Les probl\u00e8mes d\u2019antibior\u00e9sistance sont particuli\u00e8rement r\u00e9pandus dans les pays o\u00f9 le syst\u00e8me de sant\u00e9 est faible. Cela tient au manque de diagnostics ou au manque de financement du syst\u00e8me de sant\u00e9 qui causent des erreurs d\u2019utilisation ou des traitements trop courts. L\u2019hygi\u00e8ne dans les institutions sanitaires joue aussi un r\u00f4le, de m\u00eame que le manque de vaccins <a href=\"https:\/\/www.aerztezeitung.de\/Medizin\/WHO-Antibiotikaresistenz-steigt-weltweit-deutlich-an-460619.html\">[3]<\/a>.<\/p>\n\n\n\n<p>Pour ce qui est du<strong> nombre de d\u00e9c\u00e8s<\/strong>, en 2021, 7.7&nbsp;millions de personnes au monde sont d\u00e9c\u00e9d\u00e9es d\u2019une infection bact\u00e9rienne, dont <strong>1.1&nbsp;million de d\u00e9c\u00e8s directement imputables aux antibior\u00e9sistances <\/strong><a href=\"https:\/\/www.aerztezeitung.de\/Medizin\/WHO-Antibiotikaresistenz-steigt-weltweit-deutlich-an-460619.html\">[3]<\/a><strong>.&nbsp;<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-un-phenomene-mondial\"><strong>Un ph\u00e9nom\u00e8ne mondial<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>Les r\u00e9sistances se forment non seulement dans les h\u00f4pitaux, mais aussi dans la vie de tous les jours, dans la m\u00e9decine v\u00e9t\u00e9rinaire et l\u2019agriculture. Les bact\u00e9ries r\u00e9sistantes font fi des fronti\u00e8res, elles se r\u00e9pandent dans le monde entier via les \u00eatres humains, les animaux, les denr\u00e9es alimentaires et l\u2019eau. Le lien \u00e9troit entre la sant\u00e9 humaine, animale et \u00e9cologique est d\u00e9crit dans ce que l\u2019on appelle l\u2019<strong>approche One Health<\/strong>, un concept qui consid\u00e8re l\u2019antibior\u00e9sistance comme un probl\u00e8me mondial et interconnect\u00e9 <a href=\"https:\/\/www.blv.admin.ch\/blv\/fr\/home\/das-blv\/auftrag\/one-health.html\">[4]<\/a>. Ce changement de mentalit\u00e9 est important.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-un-changement-de-mentalite-a-lieu\"><strong>Un changement de mentalit\u00e9 a lieu<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>Tant le secteur public que priv\u00e9 reconnaissent de plus en plus l\u2019urgence de cette probl\u00e9matique mondiale. Ainsi la Strat\u00e9gie Antibior\u00e9sistance Suisse (StAR) lanc\u00e9e en 2015 vise-t-elle, par des mesures prises \u00e0 diff\u00e9rents niveaux, \u00e0 garantir l\u2019efficacit\u00e9 des antibiotiques \u00e0 long terme pour le maintien de la sant\u00e9 humaine et animale. Il s\u2019agit par exemple de favoriser une utilisation appropri\u00e9e des antibiotiques, de pr\u00e9venir les infections \u00e0 l\u2019h\u00f4pital, de surveiller les r\u00e9sistances et la consommation d\u2019antibiotiques, d\u2019encourager la recherche et la transmission de connaissances et de sensibiliser le grand public. Un changement de mentalit\u00e9 a donc lieu, mais il reste \u00e0 faire au niveau des incitations pour la recherche.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-les-patient-e-s-suisses-attendent-longtemps-de-nouveaux-antibiotiques\"><strong>Les patient-e-s suisses attendent longtemps de nouveaux antibiotiques<\/strong><strong><\/strong><\/h2>\n\n\n\n<p>En Suisse, les patient-e-s attendent beaucoup plus longtemps les nouveaux antibiotiques que dans d\u2019autres pays. Sur 18 substances antibact\u00e9riennes, six seulement ont \u00e9t\u00e9 autoris\u00e9es en Suisse jusqu\u2019\u00e0 fin 2019 et ne sont arriv\u00e9es sur le march\u00e9 suisse qu\u2019avec plus de 2.5&nbsp;ann\u00e9es de retard. Sur les 15 pays consid\u00e9r\u00e9s, la Suisse se classe onzi\u00e8me pour ce qui est du nombre d\u2019antibiotiques introduits. Le d\u00e9lai d\u2019attente d\u2019arriv\u00e9e d\u2019un antibiotique sur le march\u00e9 est en Suisse de 967&nbsp;jours, de sorte que notre pays atteint \u00e0 cet \u00e9gard \u00e9galement la onzi\u00e8me place. Il y a donc encore fort \u00e0 faire:<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2025\/11\/image-14.png\" alt=\"\" class=\"wp-image-31240\" style=\"width:840px\"\/><\/figure>\n<\/div>\n\n\n<p>Afin d&rsquo;\u00e9viter cette \u00ab fuite des cerveaux \u00bb, c&rsquo;est-\u00e0-dire le retrait ou la disparition des entreprises de recherche innovantes dans ce domaine, et de renforcer le d\u00e9veloppement de nouveaux antibiotiques, divers pays tels que les \u00c9tats-Unis, le Royaume-Uni et la Su\u00e8de ont test\u00e9 ou mis en place des syst\u00e8mes d&rsquo;incitation pour les antibiotiques. Ces incitations peuvent prendre la forme de primes d&rsquo;entr\u00e9e sur le march\u00e9 ou de paiements annuels garantis ind\u00e9pendants des ventes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-des-mesures-incitatives-specifiques-sont-necessaires\"><strong>Des mesures incitatives sp\u00e9cifiques sont n\u00e9cessaires :<\/strong><strong><\/strong><\/h2>\n\n\n\n<ul start=\"1\" class=\"wp-block-list\">\n<li>Les nouveaux antibiotiques doivent \u00eatre consid\u00e9r\u00e9s comme une assurance contre les crises sanitaires futures. Par cons\u00e9quent, lors de la fixation des prix, il convient de prendre en compte non seulement la valeur pour les patients, mais aussi la valeur sociale, c&rsquo;est-\u00e0-dire la garantie de la disponibilit\u00e9 de nouveaux antibiotiques comme m\u00e9dicaments de r\u00e9serve pour le traitement des bact\u00e9ries multir\u00e9sistantes.<\/li>\n\n\n\n<li>Les nouveaux antibiotiques sont conserv\u00e9s en r\u00e9serve pour des raisons m\u00e9dicales et ne sont utilis\u00e9s que lorsque les antibiotiques plus anciens \u00e9chouent. Cependant, cela signifie que les fabricants n&rsquo;ont pas de march\u00e9 et n&rsquo;ont aucun moyen de couvrir les co\u00fbts de d\u00e9veloppement, de fabrication et de distribution. Afin de garantir la disponibilit\u00e9 \u00e0 long terme des antibiotiques, des incitations \u00e0 la recherche et au march\u00e9 sont n\u00e9cessaires. Les incitations au march\u00e9 dissocient le volume des prescriptions et les ventes, ce qui permet aux entreprises de mettre \u00e0 disposition des antibiotiques de r\u00e9serve.<\/li>\n<\/ul>\n\n\n\n<p><a href=\"https:\/\/interpharma.ch\/blog\/amr-awareness-week-2025-partie-2-lavancee-insidieuse-de-lantibioresistance\/?lang=fr\">Cliquez ici pour acc\u00e9der \u00e0 la partie 2 de la s\u00e9rie d&rsquo;articles<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/interpharma.ch\/blog\/amr-awareness-week-2025-partie-3-succes-dans-la-lutte-contre-lantibioresistance\/?lang=fr\">Cliquez ici pour acc\u00e9der \u00e0 la partie 3 de la s\u00e9rie d&rsquo;articles<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/interpharma.ch\/themen\/a-la-pointe-de-la-recherche-et-developpement\/resistance-aux-antibiotiques\/?lang=fr\">Plus de documents sur l\u2019antibior\u00e9sistance et l\u2019industrie pharmaceutique.<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf\">[1]<\/a> <a href=\"https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf\">Tackling Drug-Resistant Infections Globally: Final Report and Recommendations<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.newsd.admin.ch\/newsd\/message\/attachments\/90528.pdf\">[2]<\/a> <a href=\"https:\/\/www.newsd.admin.ch\/newsd\/message\/attachments\/90528.pdf\">Faktenblatt Swiss Antibiotic Resistance Report 2024<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.aerztezeitung.de\/Medizin\/WHO-Antibiotikaresistenz-steigt-weltweit-deutlich-an-460619.html\">[3]<\/a> <a href=\"https:\/\/www.aerztezeitung.de\/Medizin\/WHO-Antibiotikaresistenz-steigt-weltweit-deutlich-an-460619.html\">WHO:<\/a><a href=\"https:\/\/www.aerztezeitung.de\/Medizin\/WHO-Antibiotikaresistenz-steigt-weltweit-deutlich-an-460619.html\"> Antibiotikaresistenz steigt weltweit deutlich an<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.blv.admin.ch\/blv\/fr\/home\/das-blv\/auftrag\/one-health.html\">[4]<\/a> <a href=\"https:\/\/www.blv.admin.ch\/blv\/fr\/home\/das-blv\/auftrag\/one-health.html\">Une seule sant\u00e9 &#8211; One Health<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Organis\u00e9e \u00e0 l\u2019\u00e9chelon mondial, l\u2019\u00abAMR Awareness Week\u00bb a pour but de sensibiliser le grand public \u00e0 l\u2019antibior\u00e9sistance et de faire progresser les approches de solutions. Cette s\u00e9rie de blogs propose un aper\u00e7u du r\u00f4le de l\u2019industrie pharmaceutique dans la lutte contre l\u2019antibior\u00e9sistance. On appelle antibior\u00e9sistance ou r\u00e9sistance aux antibiotiques la capacit\u00e9 des bact\u00e9ries \u00e0 s\u2019adapter [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":9150,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[115,120],"class_list":["post-11950","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-recherche-fr","tag-innovation-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance\" \/>\n<meta property=\"og:description\" content=\"Organis\u00e9e \u00e0 l\u2019\u00e9chelon mondial, l\u2019\u00abAMR Awareness Week\u00bb a pour but de sensibiliser le grand public \u00e0 l\u2019antibior\u00e9sistance et de faire progresser les approches de solutions. Cette s\u00e9rie de blogs propose un aper\u00e7u du r\u00f4le de l\u2019industrie pharmaceutique dans la lutte contre l\u2019antibior\u00e9sistance. On appelle antibior\u00e9sistance ou r\u00e9sistance aux antibiotiques la capacit\u00e9 des bact\u00e9ries \u00e0 s\u2019adapter [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T12:45:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-12T14:23:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-1200x1200.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance\",\"datePublished\":\"2025-11-18T12:45:31+00:00\",\"dateModified\":\"2026-03-12T14:23:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/\"},\"wordCount\":1343,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-scaled.png\",\"keywords\":[\"Recherche\",\"Innovation\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/\",\"name\":\"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-scaled.png\",\"datePublished\":\"2025-11-18T12:45:31+00:00\",\"dateModified\":\"2026-03-12T14:23:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-scaled.png\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-scaled.png\",\"width\":2560,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/","og_locale":"fr_FR","og_type":"article","og_title":"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance","og_description":"Organis\u00e9e \u00e0 l\u2019\u00e9chelon mondial, l\u2019\u00abAMR Awareness Week\u00bb a pour but de sensibiliser le grand public \u00e0 l\u2019antibior\u00e9sistance et de faire progresser les approches de solutions. Cette s\u00e9rie de blogs propose un aper\u00e7u du r\u00f4le de l\u2019industrie pharmaceutique dans la lutte contre l\u2019antibior\u00e9sistance. On appelle antibior\u00e9sistance ou r\u00e9sistance aux antibiotiques la capacit\u00e9 des bact\u00e9ries \u00e0 s\u2019adapter [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/","og_site_name":"Interpharma","article_published_time":"2025-11-18T12:45:31+00:00","article_modified_time":"2026-03-12T14:23:37+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-1200x1200.png","type":"image\/png"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance","datePublished":"2025-11-18T12:45:31+00:00","dateModified":"2026-03-12T14:23:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/"},"wordCount":1343,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-scaled.png","keywords":["Recherche","Innovation"],"inLanguage":"fr-FR","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/","name":"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-scaled.png","datePublished":"2025-11-18T12:45:31+00:00","dateModified":"2026-03-12T14:23:37+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-scaled.png","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2021\/11\/Blog-thumbnail-scaled.png","width":2560,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/amr-awareness-week-2025-partie-1-lavancee-insidieuse-de-lantibioresistance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"AMR awareness week 2025, partie 1: L\u2019avanc\u00e9e insidieuse de l\u2019antibior\u00e9sistance"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/11950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=11950"}],"version-history":[{"count":2,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/11950\/revisions"}],"predecessor-version":[{"id":15681,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/11950\/revisions\/15681"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/9150"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=11950"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=11950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}